Xi`An Sobeo Biotech Co., Ltd
Xi`An Sobeo Biotech Co., Ltd is a Chinese company based in Xi'an that focuses on the identification, development, and manufacturing of botanical extracts and their derivatives. The organization positions itself as a provider with strong research and development capabilities and emphasizes the use of advanced production technologies to innovate herbal extracts. These innovations are directed toward applications in the pharmaceutical, nutraceutical, and cosmetic sectors, reflecting a diversified portfolio that aligns with global demand for plant-based and natural product ingredients.
The company maintains certifications that underscore its quality and regulatory alignment, including QS, ISO series, Kosher, and Halal certifications. These credentials indicate a commitment to quality management systems and compliance with international standards, potentially enhancing credibility for customers across different regions and market segments. By leveraging its R&D strength, Xi`An Sobeo Biotech Co., Ltd aims to deliver botanical extracts and derivatives that meet the specification needs of pharmaceutical and nutraceutical products, as well as cosmetic formulations.
In addition to manufacturing, the enterprise operates as an importer, distributor, and agent for plant extracts, active pharmaceutical ingredients (APIs), and pharmaceutical excipients. This diversification suggests an integrated approach to supply chain management, enabling broader access to raw materials and related components for its customers. The sales and distribution arm is described as having a well-established network that supports supply and marketing activities on a global scale, which could facilitate international sourcing and distribution of botanical extracts and associated ingredients.
Overall, Xi`An Sobeo Biotech Co., Ltd presents itself as a research-driven producer of plant-based extracts with a presence in the import/export landscape for pharmaceutical inputs. While explicit details about product lines, production capacities, or specific market segments beyond the broad sectors of pharma, nutraceuticals, and cosmetics are not provided, the company’s stated certifications and global distribution capabilities point to a profile focused on quality, regulatory readiness, and international reach.
